Answers are grounded in this paper and cite their sources.
Gaucher disease (GD) is a lysosomal disorder associated with hyperferritinemia and altered hepcidin levels. This study evaluated the effect of GD-specific treatment on serum hepcidin and interleukin-6 (IL-6) in seven treatment-naïve Brazilian patients with type 1 GD. Concentrations were measured before and after initiation of treatment. Hepcidin levels significantly decreased and IL-6 showed a downward trend. These results suggest that hepcidin may also exert endocrine effects in GD-related iron metabolism.
No takes yet. Share an insight, caveat, or question.
Koppe et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: